glp-1 medicines How medications are transforming diabetes and weight loss treatment Discovery of GLP-1–Based Drugs for

Schedule follow-up to monitor for post-operative side effects or complications Schedule early outpatient or virtual visit 3 to 7 days of restart to monitor for GI symptoms, hypoglycemia if used in combination with other glucose-lowering agents, wound concerns, or infection

Focus on your health with a brand that takes your well-being as seriously as you do.

Terns Pharmaceuticals reports topline 12-week data from its phase 2 trial evaluating oral GLP-1 receptor agonist TERN-601 in obesity

Initial pharmacotherapy Glucagon While there may be some data to support glucagon in beta-blocker overdoses, the data on its use in calcium channel blocker overdoses has been lackluster to date

Tang J, Li B, Howard CB, et al